Next Article in Journal
Comparative Assessment of the Sensitivity of Ten Commercial Rapid Diagnostic Test Kits for the Detection of Plasmodium
Next Article in Special Issue
Effects of Escherichia coli and Proteus mirabilis on the Growth and Aggregation of Calcium Oxalate Crystal under Microaerobic Conditions
Previous Article in Journal
An Overview of the Evolution of Capsule Endoscopy Research—Text-Mining Analysis and Publication Trends
Previous Article in Special Issue
Urine Flow Cytometry Parameter Cannot Safely Predict Contamination of Urine—A Cohort Study of a Swiss Emergency Department Using Machine Learning Techniques
 
 
Case Report
Peer-Review Record

Encrusted Uretero-Pyelitis Caused by Corynebacterium urealyticum: Case Report and Literature Review

Diagnostics 2022, 12(9), 2239; https://doi.org/10.3390/diagnostics12092239
by Andrei Valentin Rusmir 1,2, Ionut Andrei Paunescu 1,*, Sandra Martis 1, Silviu Latcu 1,2, Dorin Novacescu 1,2, Claudia Ramona Bardan 3, Flaviu Bob 4,5, Monica Licker 6,7, Mircea Botoca 1,2, Alin Cumpanas 1,2 and Razvan Bardan 1,2
Reviewer 1:
Reviewer 2:
Reviewer 3: Anonymous
Diagnostics 2022, 12(9), 2239; https://doi.org/10.3390/diagnostics12092239
Submission received: 19 August 2022 / Revised: 12 September 2022 / Accepted: 15 September 2022 / Published: 16 September 2022
(This article belongs to the Special Issue Urinary Stones and Infections)

Round 1

Reviewer 1 Report

Dear Authors, thank you for giving me the opportunity to review your valuable manuscript. There are some comments that I would like to make with the intention of improving it:

 

1.     Please, add references to the statement about treatment of EUP (Lines 38, 182)

2.     Provide the images to show regression of the encructations (Lines 115-117)

3.     Specify the year of the Khallouk oral dissolution approach (Line 192)

4.     Please, change the sentence so to make it clear there were 19 reported cases only with a total of 58 patients, out of which 3 were of pediatric age (specify the age of children, as it may reflect the velocity of the encrustation process) (Lines 201-203)

5.     Please, specify antimicrobial therapy of the remainder 2 reported cases (Line 209)

6.     Table 1: Add the columns “Year”, “Location/Country”. Add the drugs used, duration and dosages to the Columns “Antibiotic therapy” and “Urinary acidification”. It would be also valuable to give the ranges of urine pH of patients (if possible).

7.     Please change “antibiotherapy” to “antibiotic therapy” or “antimicrobial therapy” throughout the text (Lines 21, 37, 97, 99, 194, 208, Table 1, 231)

8.     Please change “sensitivity” to “susceptibility” throughout the text (Lines 90, 91, 129, 180)

 

Minor Comments:

Line 34: hospital-acquired (add hyphen)

Line 97: ciprofloxacin from the small letter

Line 99, 208: vancomycin from the small letter

Line 128, 208: urealyticum from the small letter

Line 181: change “constant” to “intrinsic

Line 182: correct to fluoroquinolones

Line 192: missing dot after Khallouk et al.

Line 197: Put the reference prior to the dot

Line 226: Please, italicize Corynebacterium urealyticum

Author Response

Please see the attachment.

Author Response File: Author Response.docx

Reviewer 2 Report

The author presented a 70-year-old female patient with solitary left functioning kidney and encrusted uretero-pyelitis caused by Corynebacterium urealyticum, which was treated by antibiotherapy and oral acidification with L-methionine. From literature review, encrusted uretero-pyelitis caused by C. urealyticum is an underdiagnosed, rare, and severe disease. Confirmation of the infection requires a special cytobacteriological examination of the urine (CBEU) technique. The treatment is initially conservative and consists in a combination of specific antibiotherapy and urinary acidification. The article is well written and provides comprehensive knowledge to the readers. 

I have some minor questions:

1.Did the patient have recurrent UTI with same pathogen before? Is there possible colonization?

2.From the EUCAST data, the pathogen of this case was sensitive to fluoroquinolones. Why did you shift Ciprofloxacin to Vancomycin? Is there clinical unstable signs?

Author Response

Please see the attachment.

Author Response File: Author Response.docx

Reviewer 3 Report

A rare disease is reported. The presentation is excellent, and have a high quality to be published on this journal.

Author Response

Dear reviewer, thank you very much for your remarks. We have tried to further improve the article.

Back to TopTop